Form 8 (OPD) (Cenkos Securities Plc)

RNS Number : 0222V
Cenkos Securities PLC
31 March 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1.  KEY INFORMATION

 

(a) Full name of discloser:

CENKOS SECURITIES PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

  Use a separate form for each offeror/offeree

CENKOS SECURITIES PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

  The latest practicable date prior to the disclosure

31 MARCH 2023

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

  If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

 

2.  POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)  Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

ORDINARY SHARES OF 1p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

  TOTAL:

0

0

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b)  Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3.  POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a)  Ordinary shares held by the directors of Cenkos Securities plc:

 

Name

No of Ordinary Shares Held

% of Issued Share Capital

Julian Morse

(Executive Director)

1,221,556

2.15

Jeremy Osler

(Executive Director)

82,945

0.15

Lisa Gordon

(Non-Executive Director)

100,000

0.18

Andrew Boorman

(Non-Executive Director)

128,152

0.23

Jeremy Miller

(Non-Executive Director)

55,000

0.1

 

(b)  Options and awards granted under Cenkos Securities plc's share plans held by the directors of Cenkos Securities plc:

 

Name

Description of award/ option

Number of Cenkos Shares

Date of Award / Grant

Exercise Price

Vesting Date from

Expiry Date

Julian Morse

 

Deferred Bonus Scheme

453,371

177,365 shares based on a 74.0p share price. Awarded on 8 April 2021

 

276,006 shares based on a 74.5p share price. Awarded on 8 April 2022

n/a

 

 

 

n/a

88,682 shares on 8 April 2023

88,683 shares on 8 April 2024

 

92,002 shares on 8 April 2023

92,002 shares on 8 April 2024

92,002 shares on 8 April 2025

 

 

n/a

 

Long Term Incentive Plan

1,460,000

6 April 2021

Nil Paid Options

Subject to performance conditions being met

486,666 shares on 6 April 2024

486,667 shares on 6 April 2025

486,667 shares on 6 April 2026

 

5 April 2031

 

 

Company Share Option Plan

40,000

26 March 2021

73.50p

Subject to performance conditions being met

26 March 2024

25 March 2031

 

Save As You Earn

44,698

16 Nov 2020

40.27p

1 Jan 2024

30 June 2024

Jeremy Osler

 

Deferred Bonus Scheme

143,188

43,356 shares based on a 74.0p share price. Awarded on 8 April 2021

 

99,832 shares based on a 74.5p share price. Awarded on 8 April 2022

 

n/a

 

 

 

n/a

21,678 shares on 8 April 2023

21,678 shares on 8 April 2024

 

33,277 shares on 8 April 2023

33,277 shares on 8 April 2024

33,278 shares on 8 April 2025

n/a

 

Long Term Incentive Plan

510,000

6 April 2021

Nil

Subject to performance conditions being met

170,000 shares on 6 April 2024

170,000 shares on 6 April 2025

170,000 shares on 6 April 2026

 

5 April 2031

 

Company Share Option Plan

40,000

26 March 2021

73.50p

Subject to performance conditions being met

 

26 March 2024

25 March 2031

 

Save As You Earn

44,698

16 Nov 2020

40.27p

1 Jan 2024

June 2024

 

(c)  Interests (unallocated shares) held by connected employee benefit trusts of Cenkos Securities plc:

 

Name

No of Ordinary Shares Held

% of Issued Share Capital

Apex Financial Services (Trust Company) Limited Services as trustee of the Cenkos Employee Benefit Trust

1,958,252

3.45

Zedra Trust Company (Guernsey) Limited as trustee of the Cenkos Employee Benefit Trust

5,303,524

9.35

TOTAL

7,261,776[1]

12.8

[1] Total represents total number of ordinary shares held within the EBTs which are unallocated under any Cenkos Securities plc incentive schemes and accordingly can be voted by the respective trustees, subject to their discretion, in accordance with the recommendations of Cenkos Securities plc

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4.  OTHER INFORMATION

 

(a)  Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b)  Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(c)  Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

31 MARCH 2023

Contact name:

JEREMY OSLER

Telephone number:

020 7397 8978

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEESDSFMFEDSEED
UK 100

Latest directors dealings